Appearance of amyloid β-like substances and delayed-typed apoptosis in rat hippocampus CA1 region through aging and oxidative stress

Journal of Alzheimer's Disease

Volumn 8, Issue 3, 2005, Pages 299-309

  Fukui, Koji ^a   Takatsu, Hirokatsu ^a   Shinkai, Tadashi ^b   Suzuki, Shozo ^b   Abe, Kouichi ^c   Urano, Shiro ^a  

^a SHIBAURA INSTITUTE OF TECHNOLOGY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^c EISAI CO LTD   (Japan)

Author keywords

Aging; Amyloid ; Cognitive deficit; Delayed type apoptosis; Hippocampus; Learning; Memory; Oxidative stress; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; REACTIVE OXYGEN METABOLITE;

AGING; ALPHA TOCOPHEROL DEFICIENCY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATMOSPHERE; COGNITIVE DEFECT; CONTROLLED STUDY; HIPPOCAMPUS; LEARNING; MAZE TEST; MEMORY; NERVE CELL; NERVE CELL NECROSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SUPPLEMENTATION;

EID: 33644597587     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2005-8309     Document Type: Article

References (38)

1. H. Rouach, C. Ribiere, M.K. Park, C. Schffer and R. Normann, Lipid peroxidation and brain mitochondrial damage induced by ethanol, Bioelectronchem. and Bioenerg. 18 (1987), 211-217.
2. M.S. Patole and T. Ramasarma, Occurrence of lipid peroxidation in brain microsomes in the presence of NADH and vanadate, J. Neurochem. 51 (1988), 491-496.
3. B. Halliwell, Oxidants and the cerebral nervous system: some fundamental questions, Acta Neurol. Scand. 126 (1989), 23-33.
4. C. Francois, J. Nguyen-Legros and G. Percheron, Topographical and cytological localization of iron in rat and monkey brains. Brain Res. 215 (1981), 317-322.
5. K.L. Double, M. Maywald, M. Scmittel, P. Riederel and M. Gerlach, In vitro studies of ferretin iron release and neurotoxity, J. Neurochem. 70 (1983), 2492-2499.
6. S. Urano, Y. Sato, T. Otonari, S. Makabe, S. Suzuki, M. Ogata and T. Endo, Aging and oxidative stress in neurodegeneration, BioFactors 7 (1998), 103-112.
7. J. Nourooz-Zadeh, E.H. Liu, B. Yhlen, E.E. Anggard and B. Halliwell, F4-isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer's disease, J. Neurochem. 72 (1999), 734-740.
8. M.A. Lovell, C. Xie and W.R. Markesbery, Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampul culture, Neurobiol. Aging 22 (2001), 187-194.
9. K. Hensley, N. Hall, R. Subramaniam, R. Cole, P. Harris, M. Aksenov, M. Aksenova, M. Gabbita, J.F. Wu, J.M. Carney, M.A. Lovell, W.R. Markesbery and D.A. Butterfield, Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation, J. Neurochem. 65 (1995), 2146-2156.
10. L. Lyras, N.J. Cairns, P. Jenner and B. Halliwell, An assessment of oxidative damage to protein, lipids, and DNA in brain from patients with Alzheimer's disease, J. Neurochem. 68 (1997), 2061-2069.
11. R.J. Sokol, Vitamin E and neurologic function in man, Free Rad. Biol. Med. 6 (1989), 189-207.
12. N. Doerflinger, C. Linder, K. Ouahchi, F. Hentati, M.B. Hamida, R.J. Sokol, R.H. Arai, K. Inoue, J.L. Mandel and M. Koenig, Ataxia with vitamin E deficiency: refinement of genetic localization and analysis of linkage disequilibrium by using new markers in 14 families, Am J. Hum. Genet. 56 (1995), 1116-1124.
13. K. Onodera, N. Omoi, K. Fukui, T. Hayasaka, T. Shinkai, S. Suzuki, K. Abe and S. Urano, Oxidative damage of rat cerebral cortex and hippocampus, and changes in antioxidative defense systems caused by hyperoxia, Free Rad. Res. 37 (2003), 367-372.
14. S. Urano, Y. Asai, S. Makabe, M. Matsuo, N. Izumiyama, K. Ohtsubo and T. Endo, Oxidative injury of synapse and alteration of antioxidative defense systems in rats, and its prevention by vitamin E, Eur. J. Biochem. 245 (1997), 64-70.
15. P.D. Sloane, Advance in the treatment of Alzheimer's disease, Am. Fam. Physician 58 (1997), 1577-1586.
16. F. Gomi, M. Dooly and M. Matsuo, Antioxidant capacity of rat tissues and aging, Biomed. Gerontol. 12 (1988), 51-52.
17. R.G.M. Morris, Development of water-maze procedure for studying spatial learning in the rat, J. Neurosci. Methods 11 (1984), 47-60.
18. V. Mizuhira, H. Hasegawa and M. Notoya, Microwave fixation and localization of calcium in synaptic vesicles, J. Neurosci. Methods 55 (1994), 125-136.
19. V. Mizuhira and H. Hasegawa, Microwave fixation method for cytochemistry. For conventional electron microscopy, enzymoimmunocytochemistry, autoradiography elemental distribution studies and staining methods, Eur. J. Morphol. 34 (1996), 385-391.
20. Y. Gavrieli, Y. Sherman and S.A. Ben-Sasson, Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation, J. Cell Biol. 119 (1992), 493-501.
21. D. Harman, Aging, A theory based on free radical and radiation chemistry, J. Gerontol. 11 (1956), 298-300.
22. D. Harman, Free radical theory of aging: the free radical diseases, Age 7 (1984), 111-131.
23. D. Harman, Free radical theory of aging, Mutation Research 275, 257-266.
24. D. Harman, A hypothesis on the pathogenesis of Alzheimer's disease, Annals N Y Acad. Sci. 786 (1992), 152-168.
25. T. Yusa, J.D. Crapo and B.A. Freeman, Hyperoxia enhances lung and liver nuclear superoxide generation, Biochim. Bio-phys. Acta 798 (1984), 167-174.
26. A. Boveris and B. Chance, The mitochondrial generation of hydrogen peroxide. Generation properties and effect of hyperbaric oxygen, Biochem. J. 134 (1973), 707-716.
27. 2 in red cells during exposure to hyperoxia, J. Clin.l Invest. 51 (1972), 2211-2213.
28. 2 release by lung mitochondria and microsomes, Arch. Biochem. Biophys. 217 (1982), 411-421.
29. M.A. Smith, K. Hirai, K. Hsiao, M.A. Pappolla, P.L.R. Harris, S.L. Siedlak, M. Tabaton and G. Perry, Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress, J. Neurochem. 70 (1998), 2212-2215.
30. H. Kadowaki, H. Nishitoh, F. Urano, C. Sadamitsu, A. Matsuzawa, K. Takeda, H. Masutani, J. Yodoi, Y. Urano, T. Nagano and H. Ichijo, Amyloid β induces neuronal cell death through ROS-mediated ASK1 activation, Cell Death and Differenciation 12 (2005), 19-24.
31. C. Soto, M.C. Braens, J. Alvarez and N.C. Inestrosa, Structural determination of the Alzheimer's amyloid-β-peptide, J. Neurochem. 9 (1994), 75-92.
32. X. Huang, C.S. Atwood, M.A. Hartshorn, G. Multhaup, L.E. Goldstein, R.C. Scarpa, M.P. Cuajngco, D.N. Gray, J. Lim, R.D. Moir, R.E. Tanzi and A.I. Bush, The-amyloid-β peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction, Biochemistry 38 (1999), 7609-7616.
33. E. Paradis, H. Douillard, M. Koutroumanis, C. Goodyer and A. LeBlanc, Amyloid-β-peptide of Alzheimer's disease down-regulates Bcl-2 and upregulates bax expression in human neurons, J. Neurosci. 16 (1996), 7533-7539.
34. A. Boldyrev, A. Koudinov, T. Berezov and D.O. Carpenter, Amyloid-β induced cell death is independent of free radicals, J. Alzheimer's disease 6 (2004), 633-638.
35. J. Clausen, S.A. Nielsen and M. Kristensen, Biochemical and clinical effects of an oxidative supplementation of geriatric patients, Biol. Trace Elem. Res. 20 (1989), 135-151.
36. F. Grostein, J. Chen and W.C. Willett, High dose antioxidants supplements and cognitive function in community-dwelling elderly women, Am. J Clin. Nutr. 77 (2003), 975-984.
37. M. Sano, C. Ernesto, R.G. Thomas, M.R. Klauber, K. Sshafer et al., A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's disease cooparative study, New Engl. J. Med. 336 (1997), 1216-1222.
38. J.M. Zingg and A. Azzi, Non-antioxidant activities of vitamin E, Curr. Med. Chem. 11 (2004), 1113-1133.